
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.360 | 2.770 | 0.410 |
Shares | 97.630 | 97.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.101 | 17.711 |
Price to Book | 3.612 | 3.777 |
Price to Sales | 5.374 | 5.042 |
Price to Cash Flow | 16.565 | 14.918 |
Dividend Yield | 0.831 | 0.532 |
5 Years Earnings Growth | 10.392 | 14.739 |
Number of long holdings: 51
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 10.03 | 434.82 | -3.38% | |
Alnylam | US02043Q1076 | 7.60 | 276.55 | +2.50% | |
AbbVie | US00287Y1091 | 5.98 | 188.09 | +0.50% | |
Gilead | US3755581036 | 5.46 | 98.90 | +1.04% | |
Neurocrine | US64125C1099 | 5.26 | 121.61 | +2.26% | |
Amgen | US0311621009 | 4.64 | 275.84 | +2.00% | |
Guardant Health | US40131M1099 | 4.02 | 39.74 | -5.22% | |
Royalty Pharma | GB00BMVP7Y09 | 3.22 | 32.75 | +1.99% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.19 | - | - | |
Sandoz | CH1243598427 | 3.16 | 36.68 | -0.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.21B | 0.28 | -0.90 | 4.85 | ||
LU1300848345 | 6.21B | 0.33 | -0.60 | - | ||
LU1323611266 | 4.05B | 4.34 | 0.23 | - | ||
LU1520716801 | 4.05B | 7.31 | 2.63 | - | ||
UBS luxEqSICAV USA Growth USD P Acc | 2.86B | 30.57 | 6.64 | 13.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review